https://vitalspanwire.com/news/survodutide-synchronize-2-diabetes-weight-loss-tolerabilityVitalspan Wireen2026-10-03T16:03:07.733ZSurvodutide trial shows weight loss in type 2 diabetes, with tolerability concernshttps://vitalspanwire.com/news/blood-cell-composition-biological-age-clocksVitalspan Wireen2026-10-03T11:02:18.770ZBlood-cell study sharpens interpretation of biological-age clockshttps://vitalspanwire.com/news/courage-trevogrumab-semaglutide-muscle-preservation-updateVitalspan Wireen2026-10-02T21:02:48.430ZCOURAGE update reports muscle preservation with trevogrumab during semaglutide treatmenthttps://vitalspanwire.com/news/brain-imaging-aging-alzheimers-distinct-connectivity-patternsVitalspan Wireen2026-10-02T16:03:29.140ZBrain-imaging study finds distinct patterns associated with aging and Alzheimer’shttps://vitalspanwire.com/news/sex-chromosomes-aging-disease-science-reviewVitalspan Wireen2026-10-02T11:02:49.990ZScience review examines how sex chromosomes shape aging and diseasehttps://vitalspanwire.com/news/designed-peptide-tlr4-cell-membrane-inflammatory-signalingVitalspan Wireen2026-10-01T21:02:07.619ZDesigned peptide reduces inflammatory signaling by targeting TLR4 inside cell membranes